Caxton Associates LLP Lowers Stock Position in Acadia Healthcare Company, Inc. $ACHC

Caxton Associates LLP trimmed its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 71.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 114,209 shares of the company’s stock after selling 292,334 shares during the quarter. Caxton Associates LLP’s holdings in Acadia Healthcare were worth $2,671,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. EverSource Wealth Advisors LLC increased its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the period. Federated Hermes Inc. grew its stake in Acadia Healthcare by 1.5% in the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after purchasing an additional 668 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Acadia Healthcare by 0.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after purchasing an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after purchasing an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its position in shares of Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after buying an additional 867 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $34.51 on Friday. The business has a fifty day moving average of $27.64 and a 200 day moving average of $23.18. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a market capitalization of $3.17 billion, a price-to-earnings ratio of -2.82, a price-to-earnings-growth ratio of 11.34 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same period in the prior year, the company earned $0.40 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ACHC shares. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research report on Monday, May 4th. Cantor Fitzgerald raised their target price on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Barclays lifted their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. TD Cowen upped their price target on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, UBS Group increased their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $28.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.